Evidence map›Paper›PMID 39095914›Full record

ArticleBMC research notes2024

The 26 S proteasome in Entamoeba histolytica: divergence of the substrate binding pockets from host proteasomes.

Nidhi Joshi, S K Yasir Hosen, Mohd Fahad, Anil Raj Narooka, S Gourinath, Swati Tiwari

Abstract read
In one paragraph

Article in BMC research notes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nidhi Joshi *Department of Pharmacology, University of Minnesota, Minneapolis, USA.
S K Yasir Hosen *Tata Institute of Fundamental Research, Hyderabad, 500046, India.
Mohd Fahad *Molecular Cell Biology Laboratory, School of Biotechnology, Jawaharlal Nehru University, New Delhi, 110067, India.
Anil Raj NarookaProteomics Department, Advanced Enzymes Technologies Ltd, Thane, 400604, India.
S GourinathSchool of Life Sciences, Jawaharlal Nehru University, New Delhi, 110067, India.
Swati TiwariMolecular Cell Biology Laboratory, School of Biotechnology, Jawaharlal Nehru University, New Delhi, 110067, India. swati_tiwari@mail.jnu.ac.in.

Funding

Department of Biotechnology, Ministry of Science and Technology, India Master's Thesis GrantDepartment of Science and Technology, Ministry of Science and Technology, India VI-D&P/ 569/2016-17/TDT/CIndian Council of Medical Research 5/8-1(56)/2013-14-ECD-II
6 · The paper itself

Abstract

objectiveProteasomes are conserved proteases crucial for proteostasis in eukaryotes and are promising drug targets for protozoan parasites. Yet, the proteasomes of Entamoeba histolytica remain understudied. The study's objective was to analyse the differences in the substrate binding pockets of amoeba proteasomes from those of host, and computational modelling of β5 catalytic subunit, with the goal of finding selective inhibitors.

resultsComparative sequence analysis revealed differences in substrate binding sites of E. histolytica proteasomes, especially in the S1 and S3 pockets of the catalytic beta subunits, implying differences in substrate preference and susceptibility to inhibitors from host proteasomes. This was strongly supported by significantly lower sensitivity to MG132 mediated inhibition of amoebic proteasome β5 subunit's chymotryptic activity compared to human proteasomes, also reflected in lower sensitivity of E. histolytica to MG132 for inhibition of proliferation. Computational models of β4 and β5 subunits, and a docked β4-β5 model revealed a binding pocket between β4-β5, similar to that of Leishmania tarentolae. Selective inhibitors for visceral leishmaniasis, LXE408 and compound 8, docked well to this pocket. This functional and sequence-based analysis predicts differences between amoebic and host proteasomes that can be utilized to develop rationally designed, selective inhibitors against E. histolytica.

Indexed as

Entamoeba histolyticaProteasome Endopeptidase ComplexAmino Acid SequenceBinding SitesCatalytic DomainHumansLeupeptinsModels, MolecularMolecular Docking SimulationProteasome InhibitorsProtein BindingProtozoan ProteinsSubstrate Specificitybenzyloxycarbonylleucyl-leucyl-leucine aldehydeLeupeptinsProteasome Endopeptidase ComplexProteasome InhibitorsProtozoan Proteins26S proteasomesAmoebiasisEntamoeba histolyticaMG132Protozoan parasiteUbiquitin

Identifiers

PMID39095914
PMCPMC11295364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.